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Epidural dexmedetomidineAbstract Objective: We designed this study to test whether dexmedetomidine 1 lg/kg can be an
alternative to epinephrine 5 lg/ml (1/200.000) as an adjuvant to lidocaine 2% for fastening the
extension of labor epidural analgesia into an adequate block for emergency cesarean section (CS).
Methods: Sixty patients having epidural analgesia for normal delivery who required emergency CS
were assigned to either lidocaine–epinephrine (LE) group (n= 30) received 19 ml of lidocaine 2%
and 1 ml containing 5 lg epinephrine or lidocaine–dexmedetomidine (LD) group (n= 30) received
19 ml of lidocaine 2% and 1 ml containing 1 lg/kg dexmedetomidine. If the patient feels any
discomfort (VAS >3) during surgery, intravenous fentanyl 25–50 lg was given. Sedation level
was assessed using five points numerical scale.
Results: Both groups were comparable regarding the onset time and time to maximum block
height, p value >0.05. The number of patients required intraoperative fentanyl was higher in LE
group compared to LD group, p value <0.05. The mean total fentanyl supplementation was more
in LE group compared to LD group, p value <0.001. Overall sedation score was higher in LD
group than in LE group (p value <0.001), and more patients had bradycardia in LD group
compared to LE group (p value <0.001). The mean time to two segment regression, mean time
to regression to Bromage 0 and mean time to first analgesic requirement were significantly longer
in LD group compared to LE group, p value <0.001.
Conclusion: Epidural dexmedetomidine is comparable to epinephrine as an adjuvant to epidural
lidocaine in fastening the onset of surgical anesthesia and resulted in better intraoperative analgesia
and in longer duration of sensory and motor block in the settings of converting labor epidural
analgesia for emergency CS.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epidural analgesia is commonly used to provide pain relief
during labor. To extend the epidural analgesia in labor for
352 R. Hasanein, S. Elshalemergency cesarean section (CS), a fast onset solution of local
anesthetic is required aiming to achieve rapid and good quality
of epidural anesthesia. Different solutions of local anesthetics
are used for this reason. The optimum choice of local anes-
thetic solution for achieving rapid and reliable epidural anes-
thesia for CS is still not clarified [1]. The solution used is
selected according to local policies.
Addition of other drugs to the local anesthetic as adrena-
line, bicarbonate and fentanyl has been described [2–4].
Hillyard et al. [5] reported in meta-analysis that the combi-
nation of 2% lidocaine with epinephrine for epidural top-up
provided the fastest onset of surgical anesthesia.
Dexmedetomidine is a-2 adrenergic agonist with analgesic
properties that augment local anesthetic effects when given
by epidural route [6,7]. It was demonstrated that dexmedeto-
midine enhances the local anesthetic action of lidocaine either
by causing vasoconstriction around the site of injection delay-
ing lidocaine absorption and hence prolonging its action or by
causing direct inhibition of the peripheral neuronal activity [8].
This study was designed to test whether dexmedetomidine
1 lg/kg can be an alternative to epinephrine 5 lg/ml
(1/200.000) as an adjuvant to lidocaine 2% for speeding the
onset to fasten the extension of epidural analgesia into an ade-
quate block for emergency CS in patients having epidural anal-
gesia for normal delivery who required CS.
Our primary outcome was the time for T4 loss of sensation
to cold (onset time). Secondary outcomes were maximum
block height, block duration, need for intravenous fentanyl
supplementations, side effects, and neonatal outcomes.2. Materials and methods
After obtaining institutional ethical approval, an informed
written consent was signed by each patient included in the
study; mothers were instructed and agreed not to breast-feed
their babies for 24 h. Sixty patients between 20 and 40 years
old, American Society of Anesthesiology (ASA) I–II, were
included in the study at Saad Specialist Hospital, Alkhobar,
Saudi Arabia, in the period between January 2014 and July
2015. Inclusion criteria were as follows: emergency CS in the
absence of maternal or fetal compromise (category 2, 3)
(Table 1) [9], well-functioning epidural catheter (required 2 or
less intra-partum supplementation with bupivacaine 0.125%),
and uncomplicated pregnancy with singleton pregnancy
P36 weeks of gestation. Exclusion criteria included emergency
CS with maternal or fetal compromise (category 1) (Table 1)
[9], a poorly functioning epidural catheter during the labor, if
narcotics or alpha 2 agonists rather than our regimen was given
within the previous 4 h, last intrapartum supplementation ofTable 1 Categorization of urgency of cesarean section [9].
Grade definition done at tim
Category 1 Immediate threat to life of m
rupture, severe fetal distress
Category 2 Maternal or fetal compromi
Category 3 Need early delivery but no m
elective cesarean section but
Category 4 At a time that suits the patiepidural catheter less than 2 h and if the parturient had pre-
eclampsia or eclampsia, bleeding, liver impairment, renal
impairment, diabetes mellitus or cardiac disease.
The routine method used for epidural labor analgesia in our
hospital is the administration of a bolus of 10 ml 0.125% bupi-
vacaine with 50 lg fentanyl followed by a continuous infusion
at a constant rate (10–12 ml/h) of 0.125% bupivacaine with
2 lg/ml fentanyl. An additional bolus of 5 ml 0.125% bupiva-
caine was supplemented when required aiming to have ade-
quate analgesia for labor up to T10 level.
Patients were randomly assigned by computer-generated
random numbers using sealed envelopes to one of two groups.
Group lidocaine–epinephrine (LE) (n= 30) received 19 ml of
lidocaine 2% and 1 ml containing 5 lg (1:200.000) epinephrine
((Daihan Pharm Co., Seoul, Korea) and group lidocaine–
dexmedetomidine (LD) (n= 30) received 19 ml of lidocaine
and 1 ml containing 1 lg/kg dexmedetomidine (Precedex,
Hospira, Lake Forest, IL, USA). Both solutions were identical
and labeled as test medication and freshly prepared by a phar-
macist not involved in the study who allocated the patients
according to the number in the sealed envelope. The solution
was injected over 5 min using stopwatch (4 ml/min) through
epidural catheter after negative aspiration to both blood and
CSF.
To convert the epidural analgesia to epidural anesthesia for
emergency CS patients were shifted to the operating room, and
electrocardiography, pulse oximetry, and non-invasive blood
pressure monitoring were applied. An intravenous infusion
of 500 ml Lactated Ringer’s solution started. The patient was
positioned in the supine position with a left lateral tilt using
a wedge. Baseline blood pressure and heart rate were recorded,
immediately before the top-up, assessment of both the sensory
level (cold) and the degree of motor block (modified Bromage
scale score [10]: 0, patient can raise extended leg; 1, can bend
knees; 2, can bend ankles; 3, unable to bend knees or ankles).
After injecting the study medication the block was assessed
every 2 min. Sensory block was assessed in both sides in the
midclavicular line using ice (cold sensation) and motor block
assessed by using modified Bromage Scale.
The highest sensory level was recorded; time to highest
sensory level and time from skin incision to delivery were
recorded.
Systolic blood pressure (SBP) and heart rate (HR) were
measured every 2 min, ephedrine 5 mg boluses were given if
SBP dropped <100 mmHg or >20% from baseline and
repeated every 5 min if needed, and atropine 0.5 mg boluses
were given iv if the HR was less than 55 beats/min and
repeated after 5 min if needed (maximum 2 mg).
If the patient had any discomfort during surgery
(VAS > 3), analgesic supplementation was provided bye of decision to operate
other or fetus as active bleeding, placental Abruption, uterine
se but not immediately life-threatening
aternal or fetal compromise (a parturient who has booked for an
goes into labor before her scheduled operation date)
ent and maternity team
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not satisfied general anesthesia was provided.
Recovery from sensory block was defined as the time from
injection of our test medications till the patient requested anal-
gesia (VASP 4), and recovery from motor block was defined
as time from injection of our test medications till Bromage
score = 0 (tested each ½ h postoperatively).
Our primary outcome was the time to loss of cold sensation
to T4 on both sides (compared to cold sensation on the shoul-
der), tested every 2 min from the end of the epidural injection
of the test solution. Secondary outcomes were maximum block
height, block duration, need for intravenous fentanyl supple-
mentations, side effects, and neonatal outcomes.
Sedation level was assessed every 20 min using five points
numerical scale (0 means fully awake, 1 means calm, 2 means
awake on verbal commands, 3 means awake on gentle tactile
stimulation, 4 means awake on vigorous stimulation and 5
means unarousable).
The surgeons, who were blinded to the given medication,
were asked to qualify the operative condition by the follow-
ing scale: 1 = unsuccessful, 2 = poor, 3 = acceptable and
4 = perfect.
Sample size was calculated depending on previous study
done by Lucas et al. [2]; they reported that 30% reduction in
the time for loss of cold sensation at T4 is required between
groups to be clinically significant. Hence, 30 patients per group
were calculated with an alpha value of 0.05 and power of 80%.
2.1. Statistical analysis
Data were described in terms of mean ± standard deviation
(±SD), median and range, or number of cases (frequency)
and percentages when appropriate. Comparison of numericalAssessment for e
(n=110)
Randomized (n=6
Allocated to intervenon (n=30)
Received allocaon to intervenon (n=30)
Didn’t receive allocaon to intervenon(n=0)
Lost to follow up (n=0) 
Disconnued intervenon ( (n=0)
Analysed (n=30)
Excluded from analysis (n=0)
Enrollment
Allocaon
Follow up
Analysis
Figure 1 CONSORT flow diavariables between the study groups was done using Student’s
t test for independent samples in comparing normally dis-
tributed data and Mann–Whitney U test for independent sam-
ples when data were not normally distributed. For comparing
categorical data, Chi square (v2) test was performed. Exact test
was used instead when the expected frequency is less than 5. p
values less than 0.05 were considered statistically significant.
All statistical calculations were done using computer program
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) release 15 for Microsoft Windows (2006).
3. Results
A total of 110 parturients were surveyed for their eligibility.
Thirty-two of them did not meet the inclusion criteria and
eighteen patients refused to participate. The sixty remaining
patients were randomized into two equal groups (Fig. 1). Both
groups had similar characteristics as regards age, height,
weight, gestational age and parity (Table 2).
Time to T4, duration of operation, intraoperative fluid
requirement, maximum height of the block, time to maximum
block, time to incision and time to delivery were comparable in
both groups (Table 2).
Only 4 patients in group LD required fentanyl supplemen-
tation (25 lg) compared to 11 patients in group LE (7 patients
required 25 lg and 4 patients required 50 lg); p value <0.05,
Table 2.
Also mean total fentanyl requirement was significantly less
in group LD (25 ± 0 lg) compared to group LE (34 ± 13 lg);
p value <0.001, Table 2.
Apgar scores at 1 min and 5 min were comparable in both
groups as shown in Table 2. Surgeon’s satisfaction was also
comparable in both groups (p value >0.05).ligibility 
0)
Excluded (n=32)
Declined to parcipate 
(n=18)
Allocated to intervenon(n=30)
Received allocaon to intervenon 
(n=30)
Didn’t receive allocaon to intervenon 
(n=0)
Lost to follow up (n=0)
Disconued intervenon (n=0)
Analysed (n=30) 
Excluded from analysis (n=0)
gram of the study groups.
Table 2 Demographic and intraoperative data.
Parameters Group LE
(n= 30)
Group LD
(n= 30)
Age (years) 28 ± 3 28 ± 1
Height (cm) 159 ± 4 159 ± 6
Weight (kg) 77 ± 7 76 ± 3
Gestational age (weeks) 39 ± 2 39 ± 2
Parity:
Primigravida/multigravida
10/20 9/21
Duration of operation (min) 46 ± 11 47 ± 7
Intraoperative fluid (L) 3 ± 0 2 ± 0
Time to T4 (min) 10 ± 1 10 ± 0
Max block height T3 (T1–T4) T3 (T2–T4)
Time to maximum block (min) 12 ± 1 12 ± 1
Time to incision (min) 12 ± 1 12 ± 0.5
Time to delivery (min) 16.0 ± 1.0 15 ± 1
Patients requiring fentanyl
supplementation (n)
11 (33.3%)* 4 (13.3%)
Mean total fentanyl used (lg) 34 ± 13** 25 ± 0
Apgar score at 1 min 9 (8–10) 9 (8–10)
Apgar score at 5 min 10 (9–10) 10 (9–10)
Surgeon’s satisfaction 0/0/9/21 0/0/8/22
Data are presented as mean ± SD, number, median and range.
p value > 0.05 is insignificant.
* p value <0.05 in the LE (lidocaine epinephrine) group
compared to LD (lidocaine dexmedetomidine) group.
** p value is <0.001 in the LE (lidocaine epinephrine) group
compared to LD (lidocaine dexmedetomidine) group.
Table 3 Data of pre-existing epidural analgesia.
Parameters Group LE
(n= 30)
Group LD
(n= 30)
Duration of analgesia (h) 8 ± 1 8 ± 0
Pre-existing sensory level T10 (T9–T12) T10 (T8–T12)
Pre-existing motor level 0 (0–1) 0 (0–1)
Pre-existing VAS 2.5 (2–3) 2 (2–3)
Time since last top up (h) 3 ± 0.5 3 ± 0
Data are presented as mean ± SD, median and range.
LD: lidocaine dexmedetomidine, LE: lidocaine epinephrine.
P value >0.05 is insignificant.
Table 4 Degree of sedation.
Degree of sedation Group LE (n= 30) Group LD (n= 30)
Grade 0 19 (63.3%) 2 (6.7%)
Grade 1 8 (26.7%) 5 (16.7%)
Grade 2 3 (10%) 9 (30%)
Grade 3 0 14 (46.6%)
Grade 4 0 0
Grade 5 0 0
Data are presented as number of patients (%).
p value <0.001 in the overall degree of sedation between LD
(lidocaine dexmedetomidine) group and LE (lidocaine epinephrine)
group.
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and there was no significant difference between both groups
regarding duration of analgesia, pre-existing sensory and
motor levels, pre-existing VAS and the time elapsed since the
last top-up, p value >0.05.
There was a significant difference in the overall degree of
sedation between both groups Table 4, p value <0.001. Higher
number of patients in group LE were in grade 0 (19 patients),
while in group LD higher number of patients were in grade 3
(14 patients).
There was no statistically significant difference between
groups regarding the number of patients who had hypoten-
sion, nausea and vomiting, dizziness and respiratory depres-
sion, p value >0.05 (Table 5).
The number of patients who had bradycardia were signifi-
cantly more in group LD (9 patients) compared to group LE
(none of the patients had bradycardia), p value <0.001
(Table 5).
The postoperative characteristics regarding mean time to
two segment regression, mean time to regression to Bromage
score 1 and mean time for 1st analgesic requirement were sig-
nificantly longer in group LD than in group LE, p value
(<0.001) Table 6.
4. Discussion
Our results showed that using dexmedetomidine 1 lg/kg as
adjuvant to lidocaine 2% for converting epidural analgesia
to anesthesia for emergency CS in parturient with satisfactory
epidural catheter was comparable to epinephrine 1/200.000
(5 lg/ml) as regards the fast onset time of surgical anesthesiaand resulted in better intraoperative analgesia and in longer
duration of sensory and motor block and better sedation with-
out adverse events on neonatal outcome.
Converting labor epidural analgesia to surgical anesthesia
for emergency CS is frequently needed and is considered one
of the advantages of labor epidural analgesia.
Pan et al. [11] found that 41% of pre-existing labor epidural
catheters were used for CS, showing the common practice of
extending epidural block in the presence of a well-
functioning epidural catheter.
The fast speed of onset of epidural anesthesia after top-up
doses is very important in emergency cesarean section in cer-
tain situations as was emphasized in the report of ‘‘Saving
Mother’s lives” [12].
Previous studies reported that lidocaine–epinephrine com-
bination with or without fentanyl has the fastest onset when
comparing with other local anesthetic solutions [5,13,14].
The vasoconstrictor effect of epinephrine reduces the absorp-
tion of lidocaine into the bloodstream, consequently reduces
its systemic toxicity and prolongs its duration of action [15].
However, epinephrine use can result in hypertension, tachycar-
dia and arrhythmia and should be used cautiously in hyperten-
sive, hyperthyroid and cardiac patients [16].
We compared dexmedetomidine with epinephrine in our
study as epinephrine is used as a standard adjunct to local
anesthetic due to its vasoconstrictor property [16]. We chose
the concentration of epinephrine 1:200.000, as it is the amount
generally used to produce vasoconstriction when added to
local anesthesia [16].
Previous researches have shown that single injection (over
3–5 min) of 20 ml epidural lidocaine 2% with adrenaline was
safe [17].
Table 5 Incidence of side effects.
Parameters Group LE (n= 30) Group LD (n= 30)
Hypotension 3 (10%) 5 (16.6%)
Bradycardia 0 9 (30%)*
Nausea, vomiting 3 (10%) 4 (13.3%)
Dizziness 0 0
Respiratory
depression
0 0
Data are represented as number of patients (%).
* p value is significant (<0.001) in the LE (lidocaine epinephrine)
group compared to LD (lidocaine dexmedetomidine) group.
Table 6 Postoperative characteristics.
Parameters Group LE
(n= 30)
Group LD
(n= 30)
Mean time to two segment
regression (min)
151 ± 11 161.0 ± 9*
Mean time to regression to
Bromage 0 (min)
189 ± 11 210 ± 13*
Mean time to 1st analgesic
requirement (min)
210 ± 11 242 ± 7*
Data are represented as mean ± SD.
* p value is significant <0.001 in the LE (lidocaine epinephrine)
group compared to LD (lidocaine dexmedetomidine) group.
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(T1–T4) in lidocaine epinephrine group and T2–T4 in lido-
caine dexmedetomidine group.
Although Price et al. reported extension of the block up to
C7 with no serious complications [17], others reported that,
this is unlikely to happen if top-up is injected after a previously
well-functioning epidural block [18] and can happen occasion-
ally, if the epidural catheter is misplaced in the subdural space,
a large top-up can lead to tearing of the arachnoid and leads
excessively high block [19].
In our study patients received lidocaine–epinephrine were
ready for surgery after 10 ± 1 min. And patients in lidocaine–
dexmedetomidine group were ready after 10 ± 0 min. This
coincides with the results of Price et al. [17], who reported that
92% of patients were ready for surgery within 10 min of using
lidocaine 2% with 1/200.000 epinephrine for epidural top-up.
A previous trial reported the enhancement effect of
dexmedetomidine on the local anesthetic effect of lidocaine
through a2-A adrenoceptor, which is caused either by vasocon-
striction around the site of injection resulting in reduced absorp-
tion of local anesthetic and hence prolonging its duration of
action or by direct inhibition of peripheral neuronal activity [8].
Our results support the previous studies in which
dexmedetomidine was used as an additive to local anesthetics;
Bajwa et al. [20] reported that the use of epidural dexmedeto-
midine 1.5 lg/kg as adjuvant to epidural ropivacaine resulted
in early sensory and motor block and prolonged postoperative
analgesia in patients undergoing vaginal hysterectomy and
found that it is a better adjuvant than clonidine in terms of
intra-operative and postoperative analgesia, cardiorespiratory
side effects and patient’s satisfaction. Also, Honoura et al.
[21], concluded that adding dexmedetomidine to bupivacaine
and fentanyl improved intraoperative condition and quality
of postoperative analgesia with no significant maternal orneonatal side effects. Also, El-Hennawy et al. [22] compared
dexmedetomidine and clonidine as additive to caudal bupiva-
caine in children undergoing lower abdominal surgeries and
reported that both drugs significantly improved postoperative
analgesia.
Apgar score was satisfactory in both groups at 1 min and
5 min, and this coincides with the results of Selim et al. [23]
who used dexmedetomidine along with LA for epidural anal-
gesia during labor and reported good maternal satisfaction
without deleterious side effects on uteroplacental circulation
and neonatal outcome. This is explained by the unique phar-
macokinetics of dexmedetomidine as it does not cross placenta
significantly and it is highly lipophilic and consequently
retained in placental tissue [24].
Patients in lidocaine–dexmedetomidine group required less
intravenous fentanyl supplementation than in lidocaine–epi-
nephrine group, and this could be explained by the anti-
nociceptive effect of dexmedetomidine as it is highly lipophilic
and hence rapidly distributed in neural tissues binding to alpha
2 receptors in the spinal dorsal horn cells when administered
neuroaxially [25].
Dexmedetomidine can cause systemic effects as sympa-
tholytic effect, sedation, anxiolysis as well as complications
such as hypotension and bradycardia [26].
Our study clearly shows the sedative effect of epidural
dexmedetomidine as it caused sedation score grade 3 in
46.6% of cases who were awakened by gentle tactile stimula-
tion and 30% of the patients were sedated with grade 2 seda-
tion score who were awakened by verbal commands. In the
lidocaine–epinephrine group 63.3% of patients were not
sedated, only 10% of patients were grade 2 and 26.7% of
the patients were grade 1; most probably the sedation was
related to fentanyl supplementation.
The overall sedation scores were statistically significant
with administration of dexmedetomidine.
30% of patients received lidocaine–dexmedetomidine had
bradycardia which is one of the side effects of
dexmedetomidine. The ɑ-2 agonist induced bradycardia is
explained by their central effect on reducing sympathetic
outflow [26].
Although there was tendency to hypotension in LD group,
the incidence of hypotension was statistically not significant
between groups, 10% in LE group and 16.6% in LD group.
This incidence coincides with the reported incidence of
hypotension under epidural anesthesia for CS which ranges
between 6.7% and 50% [27]. The incidence of nausea and
vomiting was also comparable in both groups 10% in LE
group and 13.3% in LD group: hypotension could be one of
the factors that induce nausea and vomiting [28].
Both groups were comparable as regards the pre-existing
block data; this excludes the presence of unequal blockade
relating to previous labor analgesia.
Song et al., compared dexmedetomidine and epinephrine as
an adjuvant to 1% mepivacaine in brachial plexus block and
concluded that dexmedetomidine is good alternative as an
adjuvant to local anesthesia in patients who are contraindi-
cated to use epinephrine [29].
There have been controversies regarding problems of breast
feeding after epidural anesthesia in parturients [30]. No studies
were done to prove the safety of breast feeding after the use of
dexmedetomidine; hence, we requested our patients to avoid
breast feeding for 24 h after delivery [30].
356 R. Hasanein, S. ElshalLimitations to our study: we mixed two drugs in each group
and this can lead to errors and delay during emergency situa-
tion [31], but we couldn’t use pre-mixed solutions as epinephr-
ine degrades by 24 h when stored at 20 C [32].
Further studies are needed to find whether smaller doses of
dexmedetomidine can be helpful in achieving fast onset time
for surgical readiness without side effects.
5. Conclusion
Epidural dexmedetomidine is comparable to epinephrine as an
adjuvant to epidural lidocaine in fastening the onset of surgical
anesthesia and resulted in better intraoperative analgesia and
in longer duration of sensory and motor block in the settings
of converting labor epidural analgesia for emergency cesarean
section.
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